Differences in Hypersensitivity Reactions to Iodinated Contrast Media: Analysis of the US Food and Drug Administration Adverse Event Reporting System Database
Authors:
Open Access
- 1 February 2023
- journal article
- research article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (5) , 1494-1502.e6
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Xiamen Municipality (3502Z20227143)
This publication has 41 references indexed in Scilit:
- Genetic risk factors for the development of allergic disease identified by genome‐wide associationClinical & Experimental Allergy, 2014
- A comparison of disproportionality analysis methods in national adverse drug reaction databases of ChinaExpert Opinion on Drug Safety, 2014
- Performance of Probabilistic Method to Detect Duplicate Individual Case Safety ReportsDrug Safety, 2014
- InternationalConsensus on drug allergyAllergy, 2014
- Recurrent Toxic Epidermal Necrolysis Secondary to Iopromide ContrastJournal of Burn Care & Research, 2013
- Classification of acute and delayed contrast media‐induced reactions: proposal of a three‐step systemContrast Media & Molecular Imaging, 2012
- Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance databaseBritish Journal of Clinical Pharmacology, 2011
- Is Computed Tomography Safe?New England Journal of Medicine, 2010
- Frequency, Outcome, and Appropriateness of Treatment of Nonionic Iodinated Contrast Media ReactionsAmerican Journal of Roentgenology, 2008
- Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency departmentAnnals of Allergy, Asthma & Immunology, 2008